FDA Warning Letter — Jubilant Draximage Radiopharmacies Inc
The FDA took a Warning Letter action against Jubilant Draximage Radiopharmacies Inc on March 10, 2016 (Kansas City, MO). The action was issued by CDER and concerns drugs products. This facility has 2 recent FDA inspections on record.
Action Details
- Facility
- Jubilant Draximage Radiopharmacies Inc
- Date
- March 10, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Center
- CDER
- Location
- Kansas City, MO (United States)